Table 2.
Differences between survivors and non-survivors with SARS CoV-2.
| Variables | Survival | No survival | p-value | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Sex | |||||
| Male | 340,076 | 50.40% | 50,340 | 64.10% | <0.0001 |
| Female | 334,244 | 49.60% | 28,152 | 35.90% | |
| Group Age | |||||
| <2 years | 2,383 | 0.40% | 121 | 0.20% | <0.0001 |
| 2.1–5.9 | 2,557 | 0.40% | 33 | 0.00% | |
| 6–9.9 | 4,255 | 0.60% | 39 | 0.00% | |
| 10–18.9 | 15,628 | 2.30% | 102 | 0.10% | |
| 19– <40 | 284,456 | 42.20% | 4,337 | 5.50% | |
| 40– <50 | 151,988 | 22.50% | 9,252 | 11.80% | |
| 50– <60 | 114,663 | 17.00% | 17,446 | 22.20% | |
| 60– <70 | 60,976 | 9.00% | 21,766 | 27.70% | |
| 70–79.9 | 26,723 | 4.00% | 16,741 | 21.30% | |
| 80+ | 10,691 | 1.60% | 8,655 | 11.00% | |
| Type | |||||
| Ambulatory | 564,547 | 83.70% | 8,977 | 11.40% | <0.0001 |
| Hospitalization | 109,773 | 16.30% | 69,515 | 88.60% | |
| Comorbidities | |||||
| Diabetes | 85,614 | 12.70% | 30,096 | 38.30% | <0.0001 |
| COPD | 7,085 | 1.10% | 3,813 | 4.90% | <0.0001 |
| Asthma | 17,889 | 2.70% | 1,578 | 2.00% | <0.0001 |
| Immunocompression | 6,159 | 0.90% | 1,935 | 2.50% | <0.0001 |
| Hypertension | 109,956 | 16.30% | 35,221 | 44.90% | <0.0001 |
| Cardiovascular disease | 10,572 | 1.60% | 4,175 | 5.30% | <0.0001 |
| Obesity | 116,071 | 17.20% | 19,182 | 24.40% | <0.0001 |
| Renal chronic disease | 8,635 | 1.30% | 5,529 | 7.00% | <0.0001 |
| Smoking | 48,622 | 7.20% | 6,264 | 8.00% | <0.0001 |
| Outcomes | |||||
| Pneumonia | 79,584 | 11.80% | 58,078 | 74.00% | <0.0001 |
| Invasive mechanical ventilation | 5,898 | 0.90% | 25,539 | 32.50% | <0.0001 |
| Intensive care unit | 7,514 | 1.10% | 7,890 | 10.10% | <0.0001 |
The value of p was calculated by X2 test.